Lapatinib Completed Phase 1 Trials for Bladder Cancers / Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00623064Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer